title: Treating Heart Failure with Preserved Ejection Fraction: A Challenge for Clinicians.
abstract: Despite a decline in many forms of cardiovascular disease, heart failure (HF) continues to increase. Heart failure with preserved ejection fraction (HFpEF) is common, especially among persons with multiple comorbidities. HFpEF presents many challenges for clinicians due to the incomplete understanding of the underlying mechanisms and lack of consensus on the most effective strategies for treatment. Angiotensin and beta receptor-blocking drugs, which form the cornerstone for the treatment of systolic HF, have failed to show similar benefits in patients with impaired diastolic function. This article provides an overview of drug therapy for HFpEF, including newer agents now under investigation.
authors.affiliation: Professor and Vice Chair, Department of Pharmacy Practice, University of Kansas Medical Center , Mailstop 4047, 3901 Rainbow Boulevard, Kansas City, KS 66160.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Howard